Brain-Disabling Treatments in Psychiatry

Double click on above image to view full picture

Zoom Out
Zoom In
Read a Sample Chapter

Brain-Disabling Treatments in Psychiatry

SKU# 9780826129345

Drugs, Electroshock, and the Psychopharmaceutical Complex, Second Edition

Author: Peter R. Breggin MD


Buy From:


Buy eBook:

Amazon Kindle | iBooks


From the author of Toxic Psychiatry and Talking Back to Prozac:

Peter Breggin is the conscience of American psychiatry. Once more he updates us on the real evidence with respect to the safety and effectiveness of specific psychiatric medications and ECT. This information is needed by all mental health professionals, as well as patients and families." --Bertram Karon, Ph.D., Professor of Psychology, Michigan State University, Author of The Psychotherapy of Schizophrenia

"Nowhere does false medical thinking do more harm than in the modern psychiatric argument that mental illness is easily diagnosed and then cured by a side-effect free drug. Nowhere is the correct psychiatric thinking more evident than in the books by Peter Breggin. -- William Glasser, MD, psychiatrist, author of Reality Therapy

In Brain Disabling Treatments in Psychiatry, renowned psychiatrist Peter R. Breggin, M.D., presents startling scientific research on the dangerous behavioral abnormalities and brain dysfunctions produced by the most widely used and newest psychiatric drugs such as Prozac, Paxil, Zoloft, Cymbalta, Effexor, Xanax, Ativan, Ritalin, Adderall, Concerta, Strattera, Risperdal, Zyprexa, Geodon, Abilify, lithium and Depakote.

Many of Breggin's earlier findings have improved clinical practice, led to legal victories against drug companies, and resulted in FDA-mandated changes in what the manufacturers must admit about their drugs. Yet reliance on these drugs has continued to escalate in the last decade, and drug company interests have overwhelmed psychiatric practice.

This greatly expanded second edition, supported by the latest evidence-based research, shows that psychiatric drugs achieve their primary or essential effect by causing brain dysfunction, and that they tend to do far more harm than good.

    New scientific analyses in this completely updated edition include:

  • Chapters covering every new antidepressant and stimulant drug
  • Twenty new guidelines for how to conduct non-drug therapy
  • A chapter describing how to safely withdraw from psychiatric drugs
  • A discussion of "medication spellbinding," explaining how patients fail to appreciate their drug-induced mental dysfunctions
  • Documentation of how the drug companies control research and the flow of information about psychiatric treatments

Product Details 

  • Publication Date December 17, 2007
  • Page Count 576
  • Product Form Hardback
  • ISBN 13 9780826129345
  • EISBN 9780826129352

Online Supplements 

Watch an interview with author Peter Breggin about psychiatric drugs:

Table of Contents 

    Preface: A Word About Words
    Introduction: Confirming the Science Behind the First Edition
  1. The Brain-Disabling, Spellbinding Effects of Psychiatric Drugs
  2. Deactivation Syndrome (Chemical Lobotomy) Caused by Neuroleptics
  3. Neuroleptic-Induced Anguish, Including Agitation, Despair, and Depression
  4. Severe and Potentially Irreversible Neurological Syndromes (Tardive Dyskinesia and Neuroleptic Malignant Syndrom) Caused by Neuroleptics
  5. Neuroleptic-Induced Neurotoxicity, Brain Damage, Persistent Cognitive Deficits, Dementia, and Psychosis
  6. Recent Developments in Antidepressant Label Changes
  7. Antidepressant-Induced Mental, Behavioral and Cerebral Abnormalities
  8. Lithium and Other Drugs for Bipolar Disorder
  9. Electroconvulsive Therapy (ECT) for Depression
  10. From Attention-Deficit/Hyperactivity Disorder (ADHD) to Bipolar Disorder: Diagnosing America's Children
  11. Stimulant-Induced Brain Damage, Brain Dysfunction, and Psychiatric Adverse Reactions
  12. Antianxiety Drugs, Including Behavioral Abnormalities Caused by Xanax and Halcion
  13. The Food and Drug Administration (FDA) and the National Institute of Mental Health (NIMH): Drug Company Advocates
  14. Drug Company Deceptions
  15. How to More Safely Stop Taking Psychiatric Drugs
  16. Failed Promises, Last Resorts, and Psychotherapy

  17. Appendix: Psychiatric Medications by Category